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MinireviewDNA Single-Strand Break Repair
and Spinocerebellar Ataxia
ity, note that Pol actually removes the 5-dRP after the
following step of gap filling (see Figures 1c and 1e).
Direct SSBs possess a 3-phosphate or a 3-sugar frag-
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XRCC1 is a molecular scaffold protein that appears toUnited Kingdom
play a central role in the recruitment/coordination of
various polypeptides during SSBR. XRCC1 also inter-
acts with and stimulates polynucleotide kinase (PNK),DNA single-strand break repair (SSBR) is critical for
the human homolog of T4 PNK (Whitehouse et al., 2001).the survival and genetic stability of mammalian cells.
PNK is a particularly useful enzyme for end processingThree papers have recently associated mutations in
since it possesses both a 3-DNA phosphatase and aputative human SSBR genes with hereditary spinocer-
5-DNA kinase activity, enabling it to repair both 3-ebellar ataxia. The emerging links between SSBR and
phosphate and 5-hydroxyl termini.neurodegenerative disorders are discussed.
The third step of SSBR is DNA gap filling, since most
SSBs possess a single nucleotide gap at the site ofDNA Single-Strand Break Repair (SSBR)
breakage. The DNA polymerase primarily responsibleThe association of human genetic disorders with defects
for this is Pol, which usually inserts a single nucleotide,in the DNA damage response is well established (Hoeij-
but which on occasion can extend the gap by 2–15makers, 2001). Most of the major DNA repair pathways
nucleotides. This has been most extensively studiedare represented by diseases in which that pathway is
during BER, which is consequently subclassified intoabsent or impaired. Conspicuous by their absence, how-
two pathways, denoted single nucleotide repair or longever, have been human disorders specifically associ-
patch repair, respectively. A similar dichotomy is likelyated with defects in the repair of, or response to, DNA
to exist for the repair of direct SSBs. During long patchsingle-strand breaks (SSBs). SSBs can arise either di-
repair, the insertion of multiple nucleotides creates arectly (e.g., from attack of deoxyribose by free radicals
single-stranded flap that is excised by FEN1. In the ab-such as reactive oxygen species [ROS]) or indirectly (via
sence of Pol, Pol or Pol may substitute during longenzymatic cleavage of the phosphodiester backbone,
patch gap filling.e.g., as normal intermediates of DNA base excision re-
In the final step of SSBR, the integrity of the phopho-pair [BER]). The repair of direct and indirect SSBs has
diester backbone is restored by DNA ligation. Currentcollectively been termed single-strand break repair
data suggest the involvement of DNA ligase III (Lig3)(SSBR), primarily because the same group of proteins
during single nucleotide repair and DNA ligase I (Lig1)appear to repair both types of break.
during long patch repair.SSBR can be divided into four basic steps (Caldecott,
SSBR and Spinocerebellar Ataxia with Axonal2001), beginning with DNA damage binding (Figure 1).
Neuropathy (SCAN1)Most indirect SSBs are created during BER by AP endo-
Three recent publications have raised the possibility thatnuclease (APE1), and are then “handed” to the next
mutations in polypeptides associated with the repairenzyme in the BER process in a molecular relay (Wilson
of, or response to, SSBs can result in human geneticand Kunkel, 2000). This ensures that most SSBs created
disease. Recently, Takashima et al. (2002) made theduring BER are protected from the nuclear milieu from
striking discovery that mutation of the DNA repair pro-
the very beginning. In contrast, direct SSBs are “un-
tein TDP1, a tyrosyl phosphodiesterase that can repair
scheduled” lesions and initially require an efficient sur-
abortive SSBs created by topo1, is associated with
veillance mechanism for their detection. Work from de spinocerebellar ataxia with axonal neuropathy (SCAN1).
Murcia and others suggests that this is largely achieved The association of a DNA repair protein with SCAN1
by the poly (ADP-ribose) polymerases, PARP-1 or is striking, in that this is a disease characterized by
PARP-2. PARP may fulfill a number of roles at sites neurodegeneration, but which lacks any obvious extra-
of strand breakage, including recruiting or stimulating neurological features such as genetic instability or
other repair enzymes, generating ATP for DNA ligation, cancer.
modulating chromatin structure, and inhibiting un- Topo1 transiently generates SSBs as a part of its nor-
wanted recombination. mal catalytic cycle, during which it becomes covalently
The second step of SSBR is DNA end processing. attached to the 3-terminus of the break until the SSB
Most, if not all, SSBs possess an abnormal 3-terminus, is subsequently resealed by the topoisomerase (Wang,
5-terminus, or both. These termini must be restored to 2002). Under some circumstances, such as the close
3-hydroxyl and 5-phosphate moieties in order for re- proximity of other DNA lesions, the ligation activity of
pair to be completed. Indirect SSBs created by AP endo- topo1 can be inhibited, resulting in an abortive topo1
nuclease (APE1) during BER possess a 5-deoxyribose SSB that requires DNA repair for its removal (Pouliot et
phosphate (dRP) that is usually removed by the 5-dRP al., 1999). TDP facilitates this repair process by removing
lyase activity of Pol. Although included here for simplic- the topo1 peptide from the 3-terminus of abortive topo1
DNA strand breaks. It is not known at what frequency
abortive topo1-SSBs arise “spontaneously “ in cells, but*Correspondence: k.w.caldecott@sussex.ac.uk
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Figure 1. Model for Mammalian SSBR at Direct Breaks and Indirect
Breaks during BER
At most abasic sites created during BER (“AP”), APE1 binds and
cleaves the site (a), and recruits Pol (c), which then inserts a single
nucleotide and repairs the 5-deoxyribose phosphate terminus Figure 2. Model for the Repair of Abortive Topo1 SSBs
(“dRP”) created by APE1 (e). This results in a ligatable nick that is
PARP-1/PARP-2 and TDP1 are recruited to the SSB (a). TDP1 re-sealed by recruitment of XRCC1-Lig3 (g). Under some circum-
moves the 3-topo1 peptide, thereby leaving a nick with 3-phos-stances, Pol cannot remove the 5-dRP terminus (e.g., if the dRP
phate and 5-hydroxyl termini, and PARP recruits XRCC1-Lig3 het-is oxidized or reduced). At these “stalled” repair events, recruitment
erodimer (b). XRCC1-Lig3 heterodimer replaces PARP at the breakof PARP, PCNA, and FEN1 stimulates extension of the gap by 2–15
(c) and recruits PNK to repair the 3- and 5-termini (d). The remainingnucleotides and cleavage of the resulting flap (f). The nick is subse-
nick is ligated by DNA ligase III (e).quently ligated by Lig1 (h). Note that Pol/ may participate in long
patch repair under some circumstances. Direct SSBs arising from
sugar damage, and possibly a subset of SSBs arising during BER
abortive, or irreversible, during drug treatment, by vari-(e.g., abasic sites that become “uncoupled” from APE1 or that are
cleaved by AP lyase [dotted arrow]), are bound by PARP-1 or ous mechanisms such as encounter with a DNA replica-
PARP-2, which are then activated and automodified (b). Automodi- tion fork. Indeed, repair of abortive topo1-SSBs in yeast
fied PARP recruits XRCC1-Lig3 to the SSB, which replaces PARP appears to occur primarily after its encounter with a
and forms a molecular scaffold. Damaged 5- or 3-termini (red
replication fork, presumably when the SSB has beencircles) are converted to 5-phosphate and 3-hydroxyl moieties by
converted to a DSB (Pouliot et al., 2001). Yeast Tdp1APE1 or PNK, which interact with and are stimulated by XRCC1 (d).
appears to remove the topo1 peptide from the 3-termi-Recruitment of Pol (e) enables single nucleotide gap filling at most
SSBs followed by ligation by Lig3 (g). As described for BER, above, nus of the DSB, which is then processed by homologous
at some direct breaks, gap filling may be conducted in long patch recombination.
mode by Pol or Pol/ (f), with ligation conducted by Lig1 (h). In mammalian cells, abortive topo1-SSBs may also be
Damaged termini are indicated by red circles and nascent DNA from
repaired by SSBR, before they become DSBs (Figure 2).gap filling by a red line. The major pathways are indicated by large
This is suggested by several observations. First, cellsarrows and the minor pathways by small arrows.
in which the SSBR proteins PARP or XRCC1 are inacti-
vated or inhibited are hypersensitive to camptothecin,
and cells that overexpress XRCC1 are more resistant tothat they do is suggested by studies in yeast, in which
mutation of Tdp1 can increase population doubling this drug (Park et al., 2002). However, neither XRCC1
nor PARP impact on cellular sensitivity to drugs thattimes (Vance and Wilson, 2002). This effect is not ob-
served in a strain that additionally harbors a mutation form DSBs by inhibiting the religation activity of topo2.
These data suggest that XRCC1 and PARP are requiredin topo1, supporting the idea that the slow growth phe-
notype conferred by a Tdp1 mutation arises from topo1 for the repair of topoisomerase-associated breaks, and
specifically for those associated with SSBs. Also, theactivity.
Topo1-SSBs are also increased in the presence of sensitivity of XRCC1 mutant cells to camptothecin is not
alleviated by coincubation with aphidicolin, consigningthe anticancer drug camptothecin, which inhibits the
enzyme’s religation activity (Liu, 1989). The formation of XRCC1 to a pathway that operates on topo1-SSBs that
have not encountered a replication fork (Barrows et al.,topo1-SSBs by camptothecin is reversible, since topo1
can reseal the breaks once the drug is removed. How- 1998). It remains to be shown that TDP1 operates in the
same SSBR process as XRCC1 and PARP, though thisever, a subset of drug-induced topo1-SSBs can become
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Figure 3. Related FHA Domains in PNK and
Aprataxin and Models for SSB-Induced Cell
Death in Neurons
(A) Alignment of the amino termini of apra-
taxin and PNK with the consensus FHA do-
main (NCBI, CDD pfam 00498.5). Identical
residues are boxed in blue and those residues
most highly conserved in FHA domains are
underlined. FHA residues highlighted by a red
arrow are those that directly contact a phos-
phopeptide.
(B) Models for SSBR-induced cell death in the
nervous system. Note the possibilities that
SSBs may induce cell death directly, when
detected by damage surveillance mecha-
nisms either as SSBs or after conversion to
DSBs (red box), or indirectly, by inhibiting ex-
pression of one or more essential genes (yel-
low box). (1)–(3), Possible ways in which mu-
tation of TDP1 or APTX might impact
selectively on the NS. (1), greater requirement
for SSBR in neurons than in other cells due
to greater number of SSBs. (2), TDP1 and
SCAN1 mutations result in greater SSBR de-
fect in neurons than in other cells. (3), neurons
have a lower threshold for DNA damage than
other cells, above which cell death is induced.
seems likely. For example, one function of XRCC1 is uitous presence throughout evolution, the biological
roles of most of these proteins is unknown. The linkto bind and stimulate PNK, which is ideally suited to
repairing both the 5-hydroxyl and 3-phosphate termini between aprataxin and SSBR was first suggested by a
region of homology between the amino terminus of thisthat remain at topo1 SSBs after TDP1 activity (Figure
2). Indeed, PNK homologs are known to function after polypeptide and that of human PNK (Moreira et al.,
2001). Close inspection of this region of both proteinstopo1 damage in yeast, and in S.cerevisiae it is known
that they do so with Tdp1. TDP1 may also function along- identifies the presence of a putative forkhead associated
(FHA) domain, a phosphopeptide binding motif that me-side XRCC1 at other types of break, since this enzyme
can also remove, in conjunction with PNK, termini with diates specific interactions between a number of DNA
damage response proteins (Figure 3a). The similarity3-sugar fragments typical of those arising at oxidative
SSBs or DSBs (Inamdar et al., 2002). between the amino termini of PNK and aprataxin sug-
gests that aprataxin may interact with a polypeptide thatSSBR and Ataxia Ocular-Motor Apraxia (AOA1)
Recently, two groups independently associated another is also a partner of PNK. This was recently confirmed
in our laboratory by the recovery of multiple cDNA clonesspinocerebellar ataxia syndrome, ataxia ocular apraxia
(AOA1), with mutations in a novel human gene, denoted encoding aprataxin from a yeast two-hybrid screen with
XRCC1. Moreover, multiple XRCC1 cDNA clones wereaprataxin (Date et al., 2001; Moreira et al., 2001). AOA1
is the most common form of autosomal recessive ataxia recovered in a reciprocal screen in which aprataxin was
employed as bait. However, how aprataxin might influ-in Japan and the second commonest in Portugal, after
Friedrich’s ataxia. AOA1 is characterized clinically as ence SSBR is unclear. This protein appears to be a
member of the Hint subfamily of HIT proteins, exhibitingataxia with oculomotor apraxia and, similar to SCAN1,
is associated with cerebellar atrophy and axonal motor 30% identity with the active site of rabbit and human
Hint1. Rabbit hint1 exhibits adenosine monophosphor-neuropathy. One difference between AOA1 and SCAN1
is the absence of oculomotor apraxia in the latter, a amidase activity, during which AMP is released from
substrate molecules that can be defined as AMP-X,characteristic of AOA1 that is shared with ataxia telangi-
ectasia (AT), a disease that results from mutation in the where X is a small molecule or possibly a polypeptide
(Brenner, 2002). Aprataxin may thus deadenylate XRCC1cell cycle checkpoint/DNA repair protein, ATM. Indeed,
AOA1 shares a number of the neurological features with and/or other components of DNA repair, thereby modi-
fying their enzymatic activity or providing a signalingAT, and was previously classified as Ataxia telangiecta-
sia-like syndrome (ATLS), though the extraneurological function in the response to DNA strand breakage.
Single-Strand Breaks and Neurodegenerationfeatures evident in AT are absent from AOA1. As ob-
served with SCAN1, AOA1 is a disease specifically of The association of mutations in DNA repair genes with
neurodegeneration is well established (Rolig and McKin-the NS.
Aprataxin is a member of the HIT domain superfamily non, 2000). However, AOA1 and SCAN1 are remarkable
in that the clinical phenotype appears to be restrictedof nucleotide hydrolases/transferases (Brenner, 2002).
The structure and biochemical activities of various HIT to the NS. Most notable is the absence of any evidence
for increased genetic instability or cancer in these dis-domain proteins are established but, despite their ubiq-
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eases. Why might this be the case? A number of possibil- combination of two or more might do so. Some of the
ities have been put forward to explain why the NS is possible ways in which unrepaired SSBs might lead to
commonly affected in diseases associated with defects cell death in neurons are presented (Figure 3B).
in DNA repair, but can any of these account for the Future Perspectives
apparent absolute specificity of the defects in AOA1 This review is intended to highlight the emerging possi-
and SCAN1 to the NS? bility that defects in the repair of, or response to, SSBs
First, it is possible that there is a specific requirement are associated with spinocerebellar ataxia. Identifica-
for SSBR proteins during development or maintenance tion of the genes responsible for the more than thirty
of the NS that is unrelated to DNA repair. This has also spinocerebellar ataxias that have not been genetic-
been invoked as a possible explanation for the common ally defined (http://www.ncbi.nlm.nih.gov/Omim) should
occurrence of NS defects in other repair disorders, but clarify this issue.
it seems unlikely that such a broad range of repair pro-
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in Figure 1, by which most SSBs are normally removed.
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